CAS 61969-53-7

2,5-Dihydroxy-N-(2-hydroxyethyl)benzamide

Description:

2,5-Dihydroxy-N-(2-hydroxyethyl)benzamide, with the CAS number 61969-53-7, is an organic compound characterized by its aromatic structure, which includes a benzamide moiety substituted with two hydroxyl groups at the 2 and 5 positions and a hydroxyethyl group at the nitrogen. This compound is typically a white to off-white solid and is soluble in polar solvents due to the presence of hydroxyl groups, which can engage in hydrogen bonding. The hydroxyl groups contribute to its potential as a chelating agent, allowing it to interact with metal ions. Its chemical properties may include moderate stability under standard conditions, but it could be sensitive to extreme pH or temperature variations. The presence of multiple functional groups suggests potential applications in pharmaceuticals, biochemistry, or as a reagent in organic synthesis. Safety data should be consulted for handling and storage, as with any chemical substance, to ensure proper precautions are taken.

Formula: C₉H₁₁NO₄

InChI: InChI=1S/C9H11NO4/c11-4-3-10-9(14)7-5-6(12)1-2-8(7)13/h1-2,5,11-13H,3-4H2,(H,10,14)

InChI key: InChIKey=YNCOLLPSNIHBGO-UHFFFAOYSA-N

SMILES: C(NCCO)(=O)C1=C(O)C=CC(O)=C1

Synonyms:

• Gentisic acid ethanolamide
• Benzamide, 2,5-dihydroxy-N-(2-hydroxyethyl)-
• Gentisamide, N-2-hydroxyethyl-
• 2,5-Resorcylic acid ethanolamide
• 2,5-Dihydroxy-N-(2-hydroxyethyl)benzamide

2,5-Dihydroxy-N-(2-hydroxyethyl)benzamide

CAS: 61969-53-7

Sodium citrate is a specific antibody that is used in the treatment of inflammatory bowel disease, such as Crohn's disease. It may be effective in the prevention and treatment of infectious diseases, such as HIV and hepatitis C. Sodium citrate has been shown to be an analog of sodium bicarbonate, which can be used for the prevention and treatment of acid complex diseases. The drug also has anti-inflammatory properties, which can help with symptoms associated with bowel disease or other inflammatory conditions. It is available for intravenous injection as a sterile solution containing benzalkonium chloride and water for injection.

Formula: C₉H₁₁NO₄

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 197.19 g/mol

Ref: 3D-FD123461